Targeted therapies: evolve and ... surrender!
- PMID: 21544054
- DOI: 10.1038/nrclinonc.2011.60
Targeted therapies: evolve and ... surrender!
Comment on
-
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.Sci Transl Med. 2011 Mar 23;3(75):75ra26. doi: 10.1126/scitranslmed.3002003. Sci Transl Med. 2011. PMID: 21430269 Free PMC article.
References
-
- Sci Transl Med. 2011 Mar 23;3(75):75ra26 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
